Fertin
  • Delivery systems
    • Zapliq®
    • Compressed gum
    • Extruded gum
    • Lozenge
    • Pouch powder
    • Custom delivery systems and co-development
  • Application areas
    • Nicotine
    • Cannabinoids
    • Vitamins and dietary supplements
    • Oral care
    • Energy management
    • Pain management
    • Allergy
    • Cough and cold
    • Gastrointestinal
    • Sleep and relaxation
  • Services
    • Research and development
    • Manufacturing and packaging
    • Sensory optimisation
    • Regulatory and compliance
    • Quality control and assurance
    • Intellectual property
  • News & insights
    • News
    • Insights
  • Sustainability
  • About
    • Fertin Pharma Group
    • Fertin India
    • NordicCan
    • Tab Labs
  • Careers
  • Contact
  • Search
  • Account
  • Delivery systems
    • Zapliq®
    • Compressed gum
    • Extruded gum
    • Lozenge
    • Pouch powder
    • Custom delivery systems and co-development
  • Application areas
    • Nicotine
    • Cannabinoids
    • Vitamins and dietary supplements
    • Oral care
    • Energy management
    • Pain management
    • Allergy
    • Cough and cold
    • Gastrointestinal
    • Sleep and relaxation
  • Services
    • Research and development
    • Manufacturing and packaging
    • Sensory optimisation
    • Regulatory and compliance
    • Quality control and assurance
    • Intellectual property
  • News & insights
    • News
    • Insights
  • Sustainability
  • About
    • Fertin Pharma Group
    • Fertin India
    • NordicCan
    • Tab Labs
  • Careers
  • Contact
  • Search
  • Account

Notice: Undefined variable: blog_id in /home/site/wwwroot/wp-content/themes/fertintheme/header.php on line 71
Fertin
Articles 2020
2020-09-25

Fertin takes a big leap into a more digital and diversified future

Fertin Pharma is very excited about the recent launch of our new Enterprise Resource Planning (ERP) system, which is based on the latest SAP 4/Hana platform. The new system, with more than 1,400 different SAP tiles, supports our long-term growth strategy and strong commitment to customers and partners. It enables us to increase our responsiveness

2020-06-15

Peter Halling to become new CEO of Fertin Pharma following resignation of Søren Birn

Peter Halling has been appointed CEO of Fertin Pharma and will join in August 2020. Peter brings extensive experience from working in international environments of production companies in complex and contract-driven markets. He most recently served as an Executive Vice President at Döhler Group but prior to that held various roles at Ingredion and Novozymes.

2020-05-07

Fertin Pharma Appoints John Stephen CEO of Tab Labs Subsidiary

Succeeds Tom Hoeltgen, who is set to retire in December, 2020 Fertin Pharma, a leading contract development and manufacturing organization (CDMO), has appointed John Stephen as CEO of Tab Labs, its Vancouver-based subsidiary. Stephen has been active in the dietary and supplement field for over 30 years. Fertin, which has four decades of experience and

2020-05-04

Fertin Pharma Issued U.S. Patent for Oral Delivery Tablet Formed by the Compression of Unique Sugar Alcohol Combinations

U.S. Patent No. 10,632,076 B2 further strengthens Fertin Pharma’s intellectual property (IP) portfolio Vejle, Denmark, April 28, 2020 – Fertin Pharma, a contract development and manufacturing organization (CDMO) with more than 40 years of experience, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,632,076 B2. The patent

2020-04-24

Nicotine giant expects progress in 2020 – products successful during the corona crisis

After a decline in earnings in 2018, Fertin experienced growth in 2019 and is optimistic despite the corona crisis. The top line has jumped from DKK 813 million in 2018 to DKK 882 million DKK in 2019. With CEO Søren Birn in the lead, the company has cut its staff from 674 to 569 employees since

2020-03-13

Covid-19

On 11 March, 2020, the Danish Prime Minister declared a shut-down of parts of the public sector in Denmark due to the development of Covid-19. This means that in-door assemblies with more than 100 attendees are no longer allowed and universities, schools, etc. will be closed for the next two weeks. At Fertin Pharma we

Archive
  • 2021
  • 2020
  • 2019
Deliver active and functional ingredients to your consumer in a pleasurable and effective way
Dandyvej 19, DK-7100 Vejle, Denmark
+45 7215 1300  |  fertin@fertin.com
Follow us
How can we help?
Discuss your next product with our experts today
Dandyvej 19, DK-7100 Vejle, Denmark
+45 7215 1300  |  fertin@fertin.com
Fertin Pharma 2019. All Rights Reserved.
Disclaimer | Privacy Policy | Cookie Policy | Food Safety
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.